CANIDRYL 20 MG TABLETS FOR DOGS
Land: Irland
Språk: engelsk
Kilde: HPRA (Health Products Regulatory Authority)
Preparatomtale
(SPC)
02-05-2024
Noen dokumenter for dette produktet er ikke tilgjengelig for øyeblikket, du kan sende en forespørsel til kundeservicen vår, og vi vil varsle deg så snart vi kan få dem.
Send forespørsel.
Send forespørsel.
Aktiv ingrediens:
CARPROFEN
Tilgjengelig fra:
Chanelle Pharmaceuticals Manufacturing Limited
ATC-kode:
QM01AE91
INN (International Name):
CARPROFEN
Dosering :
20 Milligram
Legemiddelform:
Tablets
Resept typen:
POM
Terapeutisk gruppe:
Canine
Terapeutisk område:
Carprofen
Indikasjoner:
N.S.A.I.D
Autorisasjon status:
Authorised
Autorisasjon dato:
2006-03-03
Preparatomtale
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Canidryl 20 mg Tablets for dogs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE INGREDIENT
Carprofen 20.0 mg/tablet
EXCIPIENTS
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet.
A plain round flat bevelled edge white tablet with a breakline on one side. The tablets can be divided into equal halves.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dogs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. As a follow
up to parenteral analgesia in the management of post-operative pain.
4.3 CONTRAINDICATIONS
Do not use in cats.
Do not use in pups less than 4 months of age.
Do not use in case of hypersensitivity to active substance or to any of the excipients.
Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastro-intestinal
ulceration or bleeding, or where there is evidence of a blood dyscrasia.
Refer to section 4.7.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
Refer to Sections 4.3 and 4.5
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 30/08/2011_
_CRN 7010826_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use in aged dogs, may involve additional risk. If such a use cannot be avoided, dogs may require careful clinical
management.
Avoid use in any dehydrated, hypovolaemic or hypotensive dog, as there is a potential risk of increased renal toxicity.
Concurrent administration of potential nephrotoxic drugs should be avoided.
NSAIDs can cause inhibition of phagocytosis and hence in the treatment
Les hele dokumentet
